share_log

UnitedHealth | 8-K: Unitedhealth Group Incorporated Agreed to Sell Its Floating Rate Notes

UnitedHealth | 8-K: Unitedhealth Group Incorporated Agreed to Sell Its Floating Rate Notes

聯合健康 | 8-K:聯合健康同意出售其浮動利率票據
美股SEC公告 ·  07/26 05:04
牛牛AI助理已提取核心訊息
On July 23, 2024, UnitedHealth Group Incorporated announced the sale of a series of notes with varying interest rates and maturities, totaling $10.85 billion. The notes range from Floating Rate Notes due in 2026 to 5.750% Notes due in 2064. The sale was conducted under agreements with several underwriters, including Wells Fargo Securities and Citigroup Global Markets. The issuance occurred on July 25, 2024, under an existing indenture with U.S. Bank Trust Company as trustee. The notes were registered under the Securities Act of 1933, as part of UnitedHealth's automatic shelf registration statement. The company filed the current report to incorporate related documents into the registration statement as exhibits, which include the Underwriting and Pricing Agreements, Officers’ Certificates, Company Orders, and the legal opinion regarding the validity of the notes.
On July 23, 2024, UnitedHealth Group Incorporated announced the sale of a series of notes with varying interest rates and maturities, totaling $10.85 billion. The notes range from Floating Rate Notes due in 2026 to 5.750% Notes due in 2064. The sale was conducted under agreements with several underwriters, including Wells Fargo Securities and Citigroup Global Markets. The issuance occurred on July 25, 2024, under an existing indenture with U.S. Bank Trust Company as trustee. The notes were registered under the Securities Act of 1933, as part of UnitedHealth's automatic shelf registration statement. The company filed the current report to incorporate related documents into the registration statement as exhibits, which include the Underwriting and Pricing Agreements, Officers’ Certificates, Company Orders, and the legal opinion regarding the validity of the notes.
2024年7月23日, 聯合健康集團宣佈發行一系列不同利率和到期期限的證券, 總額爲108.5億美元。這些證券的區間從2026年到期的浮動利率證券到2064年到期的5.750%債券。該發行是與幾家承銷商簽訂協議的情況下進行的, 包括富國證券和花旗環球市場。該發行於2024年7月25日在美國銀行信託公司作爲受託人的現有契約下發行。這些證券根據1933年證券法註冊, 屬於聯合健康的自動上架註冊聲明的一部分。該公司提交了當前報告以將相關文件作爲展品併入註冊聲明, 包括承銷和定價協議、官員證書、公司訂單和關於證券有效性的法律意見。
2024年7月23日, 聯合健康集團宣佈發行一系列不同利率和到期期限的證券, 總額爲108.5億美元。這些證券的區間從2026年到期的浮動利率證券到2064年到期的5.750%債券。該發行是與幾家承銷商簽訂協議的情況下進行的, 包括富國證券和花旗環球市場。該發行於2024年7月25日在美國銀行信託公司作爲受託人的現有契約下發行。這些證券根據1933年證券法註冊, 屬於聯合健康的自動上架註冊聲明的一部分。該公司提交了當前報告以將相關文件作爲展品併入註冊聲明, 包括承銷和定價協議、官員證書、公司訂單和關於證券有效性的法律意見。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。